National Press Club Event to Highlight Patient Safety and Discuss Policy Recommendations for Moving Forward
WASHINGTON, April 16 /PRNewswire-USNewswire/ -- The Obama administration's goal of expanding the availability of generic forms of biologic drugs - and a variety of congressional efforts to fulfill the administration's goal - will be discussed on April 21st at the National Press Club in Washington, DC when the Jefferson School of Population Health hosts a forum on the quality and safety issues surrounding the creation of a regulatory pathway for follow-on biologic drugs. Attendees will also offer recommendations and key take-away messages for policy makers on Capitol Hill and in the administration.
The outcome of this debate is likely to have far-reaching implications with regard to access, cost, safety, and therapeutic impact for thousands of patients with serious, life-threatening, and chronic diseases. For this reason, it is critical that decision makers hear from all key stakeholders who have information and insights on the various touch points of this important health care issue before reaching a conclusion.
Many important factors must be taken into consideration when developing an appropriate process to review, assess, approve, and regulate the use of follow-on biologics and other related complex molecules:
The April 21st event will be held at the National Press Club, Holeman Lounge, 529 14th Street, N.W., Washington, DC. The featured speakers at the event will be:
Also speaking will be:
A live webcast of this event is available. To register for the webcast please visit: http://www.visualwebcaster.com/event.asp?id=57562
|SOURCE Jefferson School of Population Health|
Copyright©2009 PR Newswire.
All rights reserved